Nasdaq

Hoth Therapeutics responds to market rumors, says no plans for offering

Hoth Therapeutics (HOTH) responded to recent market rumors and inquiries from shareholders regarding its financial plans and ongoing clinical trials. The company affirms that it has no plans for a ...
Yahoo Finance

Hoth Therapeutics' Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory ...

NEW YORK, Sept. 2, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, today announced combined positive findings from multiple preclinical ...
Yahoo Finance

Hoth Therapeutics Taps Lantern Pharma's PredictBBB.ai Platform -- Breakthrough AI With 94% Accuracy Driving Next-Gen Drug Development

NEW YORK, Sept. 4, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, today announced that it is leveraging Lantern Pharma's breakthrough ...
Business Insider

Why Is Hoth Therapeutics (HOTH) Stock Moving Today?

Hoth Therapeutics (NASDAQ:HOTH) stock is on the move Wednesday after the clinical-stage biopharmaceutical company announced a new partnership with LTS Therapy Systems. This partnership involves the ...